cko/CD4 mice. WT refers to the wild-type allele. In mice expressing the targeted allele, AKAP9 lacZ/Neo the lacZ/Neo cassette was excised using mice expressing flp recombinase to generate AKAP9 cko mice. AKAP9 cko mice were then bred with CD4-Cre mice to obtain AKAP9 cko/CD4 mice by excision of Exon 8. (b) Genotyping of DNA from tail biopsies of AKAP9 cko/CD4 mice and control mice. Primer pair 1 (PR1) binds after Exon 7 and before Exon 8 thereby spanning the loxP sites, yielding a 759bp fragment in mice with the mutant allele and a 579bp band for the WT allele. Primer pair 2 (PR2) binds after Exon 7 and within the loxP site yielding a PCR product of 286bp in mice with a floxed allele. (c-d) Verification of protein knock-down in purified T H 1 cells using an AKAP9 antibody that recognizes the N-terminus of AKAP9. Western blot analysis revealed that the expected 450kDa AKAP9 protein observed in wild-type samples was absent in AKAP9 Lower blots rights: loading control blots for ZAP70 (upper) and EB1 (lower). ZAP70 was developed from a membrane strip cut at the 55kDa and at the 100kDa, EB1 was developed from a membrane strip cut at the 55kDa band and at the 25kDa band.
Supplementary Methods

Generation of T cell specific AKAP9 knock-out mouse
Mice with conditional deletion of AKAP9 in CD4+ and CD8+ T cells (AKAP9 cko/CD4 ) were generated on a C57Bl/6 strain (Supplementary Figure 1a) . 
CD4 counts and surface molecule expression.
We found no differences in spleen size (Supplementary Figure 2a) , total CD4+ T cell counts in the blood, inguinal lymph node and spleen (Supplementary Figure 2b) , and distribution of L-selectin and CD44 on splenic CD4+ T cells (Supplementary Figure 2c) . These data suggest that maturation and expansion of CD4+ T cells is not dependent on AKAP9. Furthermore, surface levels of T cell receptor molecules, costimulatory molecules and CCR7 were similar in AKAP9 cko/CD4 and AKAP9 wt mice (Supplementary Figure   2d ).
AKAP9 deficient CD4+ T cells exhibit normal recruitment, homing, adhesion and migration.
To investigate T-cell accumulation at the site of inflammation, we examined recruitment to the air pouch 24 hours after installation of PBS or TNF in AKAP9 cko/CD4 and AKAP9 wt mice. Both groups showed similar recruitment to their pouch (Supplementary Figure 3a) . To examine homing to lymph nodes, naïve T-cells of AKAP9 cko/CD4 and AKAP9 wt mice were differentially labeled ex vivo and co-transferred into wild-type recipient animals. Lymph nodes and spleens were analyzed for transferred cells 3 hours later via FACS. Both LFA-1 dependent homing to the lymph node as well as LFA-1 independent homing to the spleen were similar (Supplementary Figure 3b) . To further exclude other contributions of AKAP9 to LFA-1 mediated T cell trafficking, we performed in vitro experiments. To examine adhesion, we performed a static adhesion assay on plate-bound ICAM-1. Following stimulation with CXCL12 or Mn 2+ , we observed similar adhesion to ICAM-1 (Supplementary Figure 3c) , indicating that both chemokine triggered activation of LFA-1 and binding of LFA-1 to ICAM-1 do not require AKAP9. We obtained similar results on the isolated ligands VCAM-1, E-selectin and P-selectin under flow (data not shown).
Next, we investigated the ability of AKAP9 deficient CD4+ effector cells to migrate in response to a chemokine gradient. Using ICAM-1 coated transwell inserts, we observed similar migration of AKAP9 deficient cells and wild-type controls in response to CXCL12 (Supplementary Figure 3d) , indicating intact polarization in response to the chemokine gradient and effective migration through the transwell.
We then tested the ability of differentiated T cells to adhere to, migrate on and transmigrate through TNF stimulated endothelial cells. Again, we observed similar adhesion (data not shown), comparable transmigration rates (Supplementary Figure 3e) and similar migratory speed of cells on the endothelial layer (Supplementary Figure 3f) . These data indicate that adhesion and migration both on the isolated but also on stimulated endothelial cells is not affected by AKAP9.
Co-localization of TCR with TfR and LAMP-1
To assess co-localization of TfR and LAMP-1 with the T cell receptor in a standardized manner, we used pixel-by-pixel comparison and determined the pearson's R in a computerized manner of cells in Figure   5d using the Fiji Coloc2 plugin. We observed increased co-localization of the TCR with LAMP-1 in AKAP9 wt , and increased co-localization with TfR in AKAP9 CD4/ko cells (Supplementary Figure 5) . It is noteworthy that biological meaningful co-localization is indicated by values >0.5. As both endosomal compartments are expected co-localize with the TCR, we expected values >0.5 in all groups.
